DuPont has launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The portal handles online sales transactions, with target lead times of less than one week. DuPont’s bioprocessing solutions enable sophisticated purifications and separations for therapeutics and diagnostics, with brands such as DuPont AMBERCHROM and DuPont AMBERLITE being well established…

EUROIMMUN, a PerkinElmer company, announces that its EUROIMMUN Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG) (research use only) was cited by the U.S. Centers for Disease Control and Prevention (CDC) as part of the two-step testing algorithm guidance for pre-vaccination screening for the Dengvaxia vaccine that is used to prevent future dengue disease. According to…

Proscia, the digital and computational pathology solutions provider, and Datavant, which securely connects organizations with health data, have announced a partnership that will provide life sciences companies with digitized pathology data to power the development of novel therapeutics and diagnostics. The partnership brings together Datavant’s privacy-preserving connectivity technology and the largest U.S. health data ecosystem…

International Freezer Challenge honors Univ. of Illinois with 2021 “Winning Streak Award.” By Becky Chambers Hennessy, contributing writer (This is part two of a two-part series. Read part one, Facing sustainability in the lab, here.) The University of Illinois Urbana-Champaign is continuing a hot streak in arguably the coolest competition around. The university was recognized…

By Becky Chambers Hennessy, contributing writer Scientific research leaders are taking a long look in the mirror. They see their laboratories as home to beneficial scientific breakthroughs, in areas from epidemiology and the coronavirus to climate change and greenhouse gases. They’re also recognizing them as resource-intensive spaces with enormous carbon footprints. It’s an irony that’s…

Dr. Steve Arlington, president of The Pistoia Alliance, a global not-for-profit advocating for greater collaboration in biopharma, is calling on the pharmaceutical industry to continue building on the advances in collaboration it has built over the past two years. Digital transformation has accelerated rapidly during the pandemic, which in turn has greatly improved remote patient…

ProQR Therapeutics N.V. has announced a global licensing and research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The companies will use ProQR’s proprietary Axiomer RNA editing platform to progress new drug targets toward clinical development and…

Thermo Fisher Scientific‘s clinical sequencing business and AstraZeneca announced they will co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx) to support AstraZeneca’s expanding portfolio of targeted therapies. The companies will collaborate under a multiyear, global agreement. “As the pipeline of targeted therapies expands, the availability of diagnostic tools that can interrogate multiple biomarkers simultaneously will ensure…

Revelation Biosciences (Revelation), a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease, and Petra Acquisition, a special purpose acquisition company, announces they have entered into a definitive merger agreement for a business combination that will result in Revelation Biosciences becoming a publicly traded company. An…

Fusion Antibodies, a specialist in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that is has entered into a commercial collaboration with Eurofins, a Eurofins Scientific SE group company; a provider of products and services to the drug discovery industry. As leading global innovation-driven and customer-focused providers of antibody…

Life science and drug discovery researchers interested in bioluminescent tools will have the opportunity to hear from global thought leaders on the possibilities and applications of luciferase technologies during the upcoming Discover Glo 2021 virtual seminar series. Hosted by Promega and held September 13-16, the series will advance understanding in important therapeutic areas such as…

By Jennifer Chu | MIT News Office Squirting a jet of water through a drop of liquid may sound like idle fun, but if done precisely, and understood thoroughly, the splashy exercise could help scientists identify ways to inject fluids such as vaccines through skin without using needles. That’s the motivation behind a new study…

Recent work by a team of researchers at Queen’s University Belfast and University College London reports on a newly developed strategy for the manufacture of a high drug loaded amorphous solid dispersion (HDASD) using a hot-melt extrusion (HME) based platform(1). Around 80% of new drug candidates that emerge are classified as poorly soluble(2). Enhancement of…

C. Light Technologies, a neurotech and AI company, announces it has received an investment from the Alzheimer’s Drug Discovery Foundation (ADDF) through its Diagnostics Accelerator, a collaborative research initiative supported by Leonard A. Lauder, Bill Gates, the Dolby family, the Charles and Helen Schwab Foundation, Jeff Bezos and MacKenzie Scott among other leading philanthropists. This…

PerkinElmer announced they have four new ready-to-use AlphaLISA KRAS kits, designed to help scientists better understand complex KRAS protein structures and mutations so they can more easily, quickly and precisely identify potential new therapeutic candidates for a wide range of prevalent cancers. Researchers will now be able to choose between PerkinElmer’s HTRF or AlphaLISA assays…

Atlas Antibodies has agreed to acquire evitria, developer of transient recombinant antibody expression in CHO cells. This transformative acquisition brings together a leading provider of highly validated research antibodies and a front-runner in the field of custom recombinant antibody expression. Since its inception in 2010, evitria has been singularly focused on transient expression of recombinant…

Lonza and CN Bio have entered into a distribution agreement whereby Lonza will supply a selection of hepatic cells to be prequalified by CN Bio for use in their PhysioMimix Single-and Multi-Organ MPS to transform the way human-relevant pre-clinical data is generated. With prequalified cells, customers can avoid having to trial numerous cell types to…

SRI International (SRI) has entered a research collaboration with Sanofi, leveraging SRI’s SynFini artificial intelligence (AI)-guided, automated synthetic-chemistry system platform. The collaboration will discover and develop lead candidates in multiple high-profile drug-discovery programs at Sanofi. SRI’s SynFini platform combines AI and automation to accelerate small molecule drug discovery and development, and thereby bring new drugs…

Roquette, a provider of naturally derived pharmaceutical excipients, announces the opening of its new pharma online marketplace, powered by Knowde. The e-commerce platform will provide users with access to Roquette’s trusted and reliable flagship pharmaceutical and biopharmaceutical offerings at smaller quantities for the first time. Established as part of an initiative to better support manufacturers…

MOBILion Systems has launched MOBIE, the first commercial High-Resolution Ion Mobility (HRIM) product that addresses characterization challenges faced during biopharmaceutical drug development and quality monitoring. MOBIE provides fast, efficient separations with superior resolution and reproducibility, faster, simpler method development and greater instrument uptime. This highly anticipated new technology will help accelerate and simplify the workflows…

by Oak Ridge National Laboratory An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Michelle Lehman/ORNL, U.S. Dept. of Energy. In early 2020, when the…

PerkinElmer has announced that it is providing its PhenoVue Cell Painting Kits to the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) consortium. The consortium, spearheaded by the Broad Institute of MIT and Harvard and including leading pharmaceutical companies and non-profit research organizations, is focused on creating and sharing the world’s largest public cell imaging data…

Selux Diagnostics, specialists in personalized diagnostics to combat superbug infections and fight antibiotic resistance, has been awarded an additional $14.6 million in funding from the Biomedical Advanced Research and Development Authority (BARDA), part of Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. BARDA modified the…

Medial diagnostics company Cytovale has announced the first enrollment in a clinical trial of the Cytovale system and IntelliSep test to aid in the rapid diagnosis of sepsis in the emergency room (ER). The trial, A Clinical Validation Solving the Question of Inflammation or Sepsis Hastily in the Emergency Department Protocol (CV-SQuISH-ED), is a multi-site,…

Lonza has launched the next generation of its popular Nucleofector Platform. For more than 20 years, Nucleofector Technology has been an effective non-viral cell transfection method, which can be used even for hard-to-transfect cells, such as primary cells and pluripotent stem cells. Now, with an updated core unit and even more intuitive software, the next…